Sep 19, 2017· Comment from National Consumers League· FDA-2017-N-3615-0056
Filed on regulations.gov — full text not in the inline record.
FDANonrulemakingFDA-2017-N-3615
Administering the Hatch-Waxman Amendments: Ensuring an Appropriate Balance Between Innovation and Access
RIN
—
Last modified
Aug 12, 2022
Comment window
closed 3175d ago
National Consumers League filings
1
Activity
National Consumers League filed 1 comment on this docket between Sep 19, 2017 and Sep 19, 2017. 24 other organizations filed here. The comment window closed 3175d ago.
What National Consumers League filed (1)
Abstract
OPEN
View on regulations.gov →Co-filers (24)
See everyone who commented →- National Consumers LeagueTHIS ORG1 filing · confidence 85%
- Alliance for the Adoption of Innovations in Medicinetrade assoc.2 filings · confidence 85%
- American Medical Associationtrade assoc.1 filing · confidence 97%
- American Pharmacists Association (APhA)trade assoc.1 filing · confidence 97%
- American Society of Clinical Oncologytrade assoc.1 filing · confidence 85%
- Apotex Corpunverified attribution1 filing · confidence 70%
- Association for Accessible Medicinestrade assoc.1 filing · confidence 97%
- Blue Cross Blue Shield Associationtrade assoc.1 filing · confidence 85%
- Coalition to Reduce Spendingtrade assoc.1 filing · confidence 85%
- Consumers Union et alunverified attribution1 filing · confidence 70%
- Eli Lilly and Companyunverified attribution1 filing · confidence 70%
- EveryLife Foundation for Rare Diseasestrade assoc.1 filing · confidence 85%
- Global Healthy Living Foundationtrade assoc.1 filing · confidence 85%
- Healthcare Supply Chain Associationtrade assoc.1 filing · confidence 85%
- National Alliance on Mental Illnesstrade assoc.1 filing · confidence 85%
- National Association of Chain Drug Storestrade assoc.1 filing · confidence 97%
- National Community Pharmacists Associationtrade assoc.1 filing · confidence 97%
- National Health Counciltrade assoc.1 filing · confidence 85%
- National Multiple Sclerosis Societytrade assoc.1 filing · confidence 85%
- Nephron Pharmaceuticals Corporationunverified attribution1 filing · confidence 70%
- Partnership for Drug-Free Kidstrade assoc.1 filing · confidence 85%
- Pfizer Inc.unverified attribution1 filing · confidence 70%
- Pharmaceutical Care Management Associationtrade assoc.1 filing · confidence 85%
- Teva Pharmaceutical Industries Ltd.unverified attribution1 filing · confidence 70%
- Union for Affordable Cancer Treatmentunverified attribution1 filing · confidence 70%